New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 4, 2014
07:47 EDTJEC, PFEJacobs Engineering announces collaboration with Pfizer
Jacobs Engineering Group (JEC) announced a collaboration with Pfizer (PFE) on a modular process system to address the rapidly changing requirements of localized pharmaceutical manufacturing in emerging market countries. The collaboration brings together Pfizer’s aseptic drug product process expertise and Jacobs’ capabilities in modular engineering, fabrication, and testing to create a Rapid Deployment Module that integrates modular equipment, fully-automated control systems and single-use technology for bags, mixers, sterile connectors, manifolds and filters. The production systems are currently in their final stages of validation at a number of local pharmaceutical manufacturing sites around the world.
News For JEC;PFE From The Last 14 Days
Check below for free stories on JEC;PFE the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
September 17, 2014
07:43 EDTPFEBofA/Merrill to hold a conference
Subscribe for More Information
September 16, 2014
11:51 EDTPFEOECD looks to close tax loopholes with new proposals
Subscribe for More Information
07:47 EDTJECJacobs Engineering ups ownership in Jacobs ZATE
Subscribe for More Information
07:46 EDTJECJacobs Engineering awarded contract option at NASa Marshall Space Flight Center
Subscribe for More Information
07:19 EDTPFECompanies' share buybacks at fasttest clip since 2007, WSJ reports
Companies are buying back their own shares at its fastest pace since the financial crisis to fuel a stock rally, reports the Wall Street Journal. According to Birinyi Associates, companies have bought back $338.3B of stock in 1H14, the most since 2007. Citing an analysis by Barclays, companies with the largest buyback programs by dollar value have outperformed the broader market by 20% since 2008. Reference Link
September 15, 2014
09:25 EDTPFEJPMorgan biotech analysts hold an analyst/industry conference call
Analysts assess Pfizer's M&A options on an Analyst/Industry conference call to be held on September 15 at 10 am.
07:27 EDTPFEIBC Life Sciences to hold a conference
Subscribe for More Information
07:27 EDTPFEPfizer acquisition could drive shares higher, says JPMorgan
Subscribe for More Information
September 14, 2014
13:32 EDTPFEPfizer shares look cheap, Barron's says
Subscribe for More Information
September 12, 2014
10:32 EDTPFEPfizer CEO says company still open to inversion deal, FT says
Pfizer (PFE) CEO Ian Read said U.S. rhetoric against tax inversions has been "political theater" ahead of midterm elections and made clear that his company is still open to a potential tax-saving acquisition, according to Financial Times, which added Read's comment about not being “held hostage” over price would likely be read as a signal the company might look elsewhere after being rebuffed by AstraZeneca (AZN). The Fly notes that Bloomberg previously reported, citing people familiar with the matter, that Pfizer is looking at targets other than AstraZeneca, including Actavis (ACT). Shares of Actavis trading in New York are up 2% this morning. Reference Link
September 9, 2014
07:45 EDTJECJacobs Engineering receives contract extension from EDF Energy
Jacobs Engineering Group announced that its contract to provide project services to EDF Energy for its eight nuclear power station sites in the United Kingdom has been extended. Company officials did not disclose the contract value, but noted that the contract is extended by 12 months with an option for a further 12 months. Jacobs is providing a range of project services to support EDF Energy’s program of maintenance and life extension projects at the stations. EDF Energy’s eight stations have a combined capacity of almost 8.8 million kilowatts, making it the UK’s largest generator of low carbon electricity.
September 8, 2014
07:15 EDTPFEIBC Life Sciences to hold a conference
10th Annual Cell Line Development & Engineering Conference to be held in Berkeley, California on September 8-10.
September 5, 2014
11:20 EDTJECJacobs joint venture selected by FDOT
Jacobs Engineering announced today its joint venture with HDR is part of the I-4 Mobility Partners team selected by the Florida Department of Transportation to deliver the I-4 Ultimate Project in Orange and Seminole Counties, Florida. I-4 Mobility Partners is comprised of Skanska Infrastructure Development and John Laing, Skanska, Granite, Lane Construction Joint Venture, and HDR and Jacobs as the Design Joint venture. Under the terms of the contract, the HDR/Jacobs joint venture is delivering final design of the project, including roadway/traffic control, drainage, structures, intelligent traffic systems, signing and signalization, lighting, landscaping and aesthetics. The $2.32B I-4 Ultimate project includes the reconstruction of 21 miles of I-4, reconstructing 15 major interchanges, constructing more than 140 bridges, adding four variable priced toll express lanes in the median, and completely rebuilding the general use lanes along the entire corridor. The project is being procured by FDOT as a public-private partnership.
September 4, 2014
16:05 EDTPFEPfizer granted orphan status for sickle cell disease drug
Subscribe for More Information
07:23 EDTPFEAstraZeneca called for inversion clamp down as part of defense, WSJ says
Amid its defense against an unsolicited takeover bid from rival Pfizer (PFE), AstraZeneca (AZN) hired advisers with close ties to the Obama administration, who made calls to senior administration officials urging a clamp down on tax inversions, said The Wall Street Journal, citing people familiar with the previously undisclosed calls. Reference Link

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use